glp 1 drug companies Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists GLP-1 Medications for Weight Loss:

Then, we will discuss the approaches that can increase the endogenous production of GLP-1 through various stimuli

A lower, fixed dose for those who want a gentle, mindful, cosmetic approach rather than full dose weight loss

Achieve effective weight loss and appetite control with GLP-1 injections designed for lasting results

planned combo with YP05002 a unique differentiator vs Lilly and Novo

### Funding Statement SDL and AC were supported by the National Science Foundation (Grant Nos.\ CAREER DMS-1944574 and DMS-2325258) ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained

Purpose of Review This review provides a comprehensive and scholarly examination of glucagon-like peptide-1 receptor (GLP-1R) agonists, tracing their evolution from glycemic control agents in diabetes mellitus (DM) to multifaceted therapeutics with expanding indications in cardiovascular, renal, and metabolic health